Related Experiment Videos
Identification of novel Smad binding proteins
Dennis R Warner1, Emily A Roberts, Robert M Greene
1Department of Molecular, Cellular, and Craniofacial Biology, University of Louisville Birth Defects Center, ULSD, Louisville, KY 40292, USA. dennis.warner@louisville.edu
Biochemical and Biophysical Research Communications
|December 4, 2003
Summary
Researchers identified novel proteins that bind to Smads, key regulators in transforming growth factor-beta (TGF-beta) signaling pathways crucial for orofacial development. This discovery opens new avenues for understanding TGF-beta regulation and its interactions with other cellular pathways.
Area of Science:
- Developmental Biology
- Molecular Biology
- Genetics
Background:
- Transforming growth factor-beta (TGF-beta) signaling is vital for mammalian orofacial development.
- Disruptions in TGF-beta signaling, through gene deletion or receptor knockout, lead to orofacial clefts.
- Smad proteins (Smads 2 and 3) are key transcriptional regulators in TGF-beta pathways, interacting via their MH1 and MH2 domains.
Purpose of the Study:
- To identify novel Smad binding proteins in developing mouse orofacial tissue.
- To explore new mechanisms regulating TGF-beta signaling.
Main Methods:
- Yeast two-hybrid assay screening of a cDNA expression library from fetal murine orofacial tissue.
- GST pull-down assays to verify protein interactions with Smad 3 MH2 domain.
Main Results:
- Several novel Smad binding proteins were identified, including ZNF198, Pex6, 4-ET, and SF3b2.
- GST pull-down assays confirmed interactions with Smad 3's MH2 domain.
- Interactions were also observed with other Smad family members.
Conclusions:
- The identified proteins are novel Smad binding partners.
- These findings offer insights into new regulatory mechanisms of TGF-beta signaling.
- Potential interactions with other signaling pathways are revealed.